Key result
Genomic burden analysis links 144 cardiac tissue development gene signatures to cardiomyopathy phenotypes.
Why the study?
Advances in whole-genome sequencing have led to an increase in uncharacterized variants with unknown functions, prompting efforts to characterize cardiomyopathy-associated genes with rare variants and uncover their cellular contexts.
Multi-omics analysis of cardiomyopathy patients reveals that rare variants of uncertain significance are significantly enriched in cardiac development pathways and exhibit cell-type specific expression in both cardiomyocytes and endothelial cells.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for rare variant roles in cardiomyopathy; leaves open clinical utility pending larger validation studies.
Jeong et al. (2025) studied this question. Burden analysis identified 144 gene signatures enriched in pathways related to cardiac tissue development, correlated with cardiomyopathy phenotypes in 245 patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: